Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A, Hemophilia B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Large-scale testing (Phase 3)Study completedNCT06399289
What this trial is testing

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Who this might be right for
Hemophilia B
CSL Behring 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT01687608
What this trial is testing

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Early research (Phase 1)UnknownNCT02888223
What this trial is testing

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 16
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Testing effectiveness (Phase 2)UnknownNCT05441553
What this trial is testing

Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Shanghai Vitalgen BioPharma Co., Ltd. 26
Early research (Phase 1)Study completedNCT01561924
What this trial is testing

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 17
Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Not applicableNot Yet RecruitingNCT07736976
What this trial is testing

Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy Peers

Who this might be right for
Hemophilia A and B
Bahçeşehir University 58
Large-scale testing (Phase 3)Active Not RecruitingNCT05203679
What this trial is testing

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Who this might be right for
Hemophilia B
Shanghai Xinzhi BioMed Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Testing effectiveness (Phase 2)Looking for participantsNCT05641610
What this trial is testing

Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 21
Large-scale testing (Phase 3)Ended earlyNCT02484638
What this trial is testing

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
CSL Behring 25
Testing effectiveness (Phase 2)Study completedNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Very early researchStudy completedNCT03272568
What this trial is testing

Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers

Who this might be right for
HemophiliaMenstrual Flow Excessive
Emory University 3
Not applicableStudy completedNCT04731701
What this trial is testing

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 180
Next Page